BPC-157 COA: how to evaluate purity, identity and batch

BPC-157 COA It should not be just a document with a percentage of purity. When evaluating research-grade BPC-157, it is necessary to independently assess the identity of the molecule, the chromatographic profile, the amount of material, the batch number, the analytical method used, and the traceability of the result to a specific sample.

It is precisely the difference between Identity, HPLC area purity and actual amount of peptide It is among the most common sources of incorrect interpretation of analytical documentation. The product may have a high proportion of the main chromatographic peak, but this data alone does not confirm the declared mg in the vial, sterility, or clinical safety.

What should the BPC-157 COA contain?

Certificate of Analysis (COA) is an analytical document that should allow the result to be assigned to a specific test sample or batch.

With BPC-157, it makes sense to monitor mainly:

• the exact name of the analyzed material,
• batch number or lot number,
• date of analysis,
• the identification of the analytical laboratory,
• the analytical method used,
• the result of the chromatographic purity,
• molecular identification,
• quantitative determination of the quantity, if it has been made;,
• unit of result,
• and an unambiguous link between the result and the specific analyzed sample.

Identity of BPC-157

BPC-157 is a synthetic pentadecapeptide consisting of 15 amino acids. The PubChem database lists the sequence as follows:

CAS number is given for BPC-157 137525-51-0 and molecular weight approximately 1419.5 g/mol.

PubChem – BPC-157

However, what is more important than the mere inclusion of the CAS number in a COA is whether the laboratory actually performed the analytical identification of the test sample.

The CAS number printed on the document or label is not analytical evidence of identity.

What does HPLC purity mean?

HPLC – high-performance liquid chromatography – allows components of the sample to be separated and detected according to the characteristics of the chromatographic system used.

Data often referred to as peptide is often reported HPLC area purity. For example, if the main chromatographic peak represents 99 % integrated areas of detected peaks, the result can be reported as approximately 99 % area purity.

The interpretation of the result depends, for example, on:

• detection method,
• chromatographic conditions,
• integration of peaks,
• detection limits,
• and which components of the sample the given method is able to capture.

Therefore, it is not appropriate to automatically conclude from one dominant HPLC peak that the material is „degraded“ or that each smaller peak represents a specific known impurity.

HPLC purity versus the amount of BPC-157 in the vial

This is one of the most important differences when reading the BPC-157 COA.

Chromatographic purity a quantitative quantity they answer two different questions:

• HPLC purity: What is the chromatographic profile of the detected compounds?
• Assay / content: How much of the target substance was determined in the analyzed sample?

A vial labeled as 10 mg, for example, may have high chromatographic purity and at the same time a quantitative analysis may show a different value than the declared 10 mg.

These two values should therefore not be confused with each other.

Mass spectrometry and identity

Mass spectrometry provides information about the ions and molecular signals of the analyzed substance. In peptide analysis, it can be an important component of confirming the molecular identity.

With BPC-157, it makes sense to compare the measured molecular signal with the expected properties of the analyzed molecule.

However, the actual „MS confirmed“ data is more informative if the COA or the annex also contains:

• measured values,
• the expected molecular weight or the corresponding ionic forms,
• the identification of the analysed sample,
• and the analytical method used.

MS identity is not, at the same time, automatically the same as quantitative determination of mg/vial.

Quantification, reference standard and calibration curve

If the COA lists the specific amount of BPC-157 in mg, it is advisable to know:, as the quantity was calculated.

In quantitative chromatographic analysis, the following may be relevant:

• external or internal reference standard,
• calibration curve,
• concentration of the standard,
• purity or potency of the reference material,
• diluent factor,
• and the method of preparation of the analyzed sample.

Modern analytical procedures should also be evaluated based on characteristics such as specificity, accuracy, correctness, scope, and robustness of the method according to its intended purpose.

ICH – Quality Guidelines, Q2 Analytical Validation

The customer does not need to know the entire laboratory validation protocol, but when the result is significantly non-standard, it is entirely legitimate to request an explanation of the used calibration, reference standard, and calculation.

Batch number and traceability

The COA has the highest practical value when it can be unambiguously assigned to a specific batch.

It is ideal when the same batch number is found:

• on the vial or packaging,
• at COA,
• in the internal record of the supplier,
• and in the event of repeated testing of the same batch.

A generic certificate without a batch number or a document used for multiple batches has significantly lower informational value.

More detailed criteria for selecting a supplier can be found in the article 7 criteria for selecting a peptide supplier.

Endotoxins are not sterility tests

This resolution is particularly important for laboratory reports.

Bacterial Endotoxins Test is a separate test focused on bacterial endotoxins. USP lists it in the chapter <85>.

USP – Bacterial Endotoxins Test

Sterility Test It is a separate microbiological test. USP conducts sterility testing in the chapter <71>.

USP – Microbiological Quality Control Testing

Most common warning signs in BPC-157 COA

When checking an analytical document, it is worth paying attention especially in the following situations:

• COA does not have the batch number listed,
• The batch number on the COA does not match the product designation,
• The date of the analysis is not stated,
• the document only indicates the percentage of purity without analytical identity,
• COA declares mg/vial without explanation of the quantitative method,
• the units do not match between the different parts of the report,
• the measured results and the summary table contradict each other,
• the molecular weight is assigned to the wrong substance,
• one HPLC peak is interpreted as an automatic proof of stability,
• The endotoxin result is incorrectly presented as evidence of sterility,
• The same generic COA is used for multiple different batches.

The mere presence of one unclear data point does not automatically mean a problem with the material. However, it is a reason to ask the laboratory or supplier for an explanation and, if necessary, for the original analytical data to be checked.

How to compare two BPC-157 batches?

The most accurate comparison does not come from just one percent.

If both batches were tested using different methods or in different laboratories, the difference between the results may not be caused solely by the material itself. When comparing the results, the analytical procedure must also be taken into account.

What does research-grade mean with BPC-157?

The concept research-grade it describes the intended laboratory and research context of the material. It does not itself constitute pharmaceutical certification or evidence of clinical safety.

Therefore, for research-grade BPC-157, specific and traceable analytical documentation has greater value than the general marketing labeling of the product.

In 2026, BPC-157 free base and BPC-157 acetate were the subject of a separate evaluation by the U.S. FDA Pharmacy Compounding Advisory Committee as part of the 503A Bulks List process. This process is not identical to the approval of a drug.

FDA – Pharmacy Compounding Advisory Committee, July 2026

How is analytics related to the scientific research of BPC-157?

Analytical documentation answers questions about a specific sample. Scientific literature, on the other hand, examines biological mechanisms and experimental models.

These two levels should not be confused.

The mechanisms, FAK/paxillin, VEGFR2-Akt-eNOS, and the current level of scientific evidence are discussed separately in the article. BPC-157 peptide: mechanisms, preclinical research and limitations of evidence.

Currently available laboratory documents can be found in the section COA and analytical documentation.

FAQ – BPC-157 COA, HPLC and batch numbers

What does BPC-157 COA mean?

COA is Certificate of Analysis – an analytical document containing the results of testing a specific sample or batch. Its practical value depends on whether the result can be unequivocally attributed to a specific material.

Is the 99 % HPLC purity the same as the 99 % BPC-157 in the vial?

No. HPLC area purity is a chromatographic parameter. It does not automatically represent the percentage mass content of the entire vial or the mg/vial value.

How can the identity of BPC-157 be verified?

Appropriate analytical techniques, including mass spectrometry, can be used for molecular identification. Interpretation always depends on the specific method and the molecular form being analyzed.

What does mg/vial mean?

This refers to the amount of target substance specified or declared on a single vial. If it is to be an analytically measured value, it should be linked to an appropriate quantitative method.

Is the endotoxin test evidence of sterility?

No. The Bacterial Endotoxins Test and the Sterility Test are separate analytical or microbiological tests. Therefore, a low endotoxin value does not in itself confirm sterility.

Is a COA with no batch number sufficient?

Such a document has lower traceability. For the control of a specific material, it is appropriate that the batch number on the product corresponds to the batch listed in the analytical documentation.

Does the COA prove the safety of BPC-157 for humans?

No. Analytical data can characterize a specific sample, but they do not represent evidence of clinical safety or efficacy.

You can find more professional content in the section Research on peptides.

Technical and regulatory resources

1. PubChem.
   BPC-157 – CID 9941957.
   PubChem
2. International Council for Harmonization.
   Q2 – Analytical Validation.
   ICH Quality Guidelines
3. United States Pharmacopeia.
   USP – Bacterial Endotoxins Test.
   USP
4. United States Pharmacopeia.
   Microbiological Quality Control Testing – USP Sterility Tests and USP Bacterial Endotoxins Test.
   USP
5. U.S. Food and Drug Administration.
   Pharmacy Compounding Advisory Committee – Bulk drug substances related to BPC-157, July 2026.
   FDA